TFRC and glioma: The authors proposed a triple-glioma targeted delivery through the magnetically guided microemulsion by an external applied magnetic field and the specific recognition of AS1411 aptamer and T7 peptide on microemulsion surface by nucleolin and transferrin receptors overexpressed in glioma cells and the blood-brain barrier, respectively.